Skip to main content

STANDARD BIOTOOLS INC.

For the period ended Jun 30, 2026. Filed Aug 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 5, 2026

LAB$0.64+2.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

EXHIBIT LIST

ExhibitNumberDescriptionIncorporatedby ReferenceFrom FormIncorporatedby ReferenceFrom ExhibitNumberDate Filed
2.1*Agreement and Plan of Merger and Reorganization, by and among Treeline Biosciences, Inc., Standard BioTools Inc. and Siri Merger Sub, Inc. dated as of June 6, 2026.8-K2.16/8/2026
3.1Eighth Amended and Restated Certificate of Incorporation filed on February 15, 2011.10-K3.13/28/2011
3.2Amended and Restated Bylaws of Standard BioTools Inc.S-84.84/1/2022
3.3Certificate of Amendment to the Eighth Amended and Restated Certificate of Incorporation.S-84.34/1/2022
3.4Second Certificate of Amendment to the Eighth Amended and Restated Certificate of Incorporation, as amended.8-K3.11/5/2024
10.1+2026 Change of Control and Severance Plan and Participation Agreement8-K10.15/28/2026
10.2+2026 Change of Control and Severance Plan Participation Agreement, dated as of May 27, 2026, by and between Standard BioTools Inc. and Alex Kim.8-K10.25/28/2026
10.3+2026 Change of Control and Severance Plan Participation Agreement, dated as of May 27, 2026, by and between Standard BioTools Inc. and Sean MacKay.8-K10.35/28/2026
10.4+2023 Change of Control and Severance Plan Participation Agreement, as amended and restated.8-K10.45/28/2026
10.5+2023 Change of Control and Severance Plan and Participation Agreement, dated as of May 22, 2026, by and between Standard BioTools Inc. and Michael Egholm, Ph.D.8-K10.55/28/2026
10.6Form of Voting Agreement.8-K10.16/8/2026
10.7Form of Lock-Up Agreement.8-K10.26/8/2026
10.8Form of CVR Agreement.8-K10.36/8/2026
10.9+Standard BioTools Inc. 2026 Equity Incentive Plan.8-K10.16/18/2026
10.10+Standard BioTools Inc. Amended and Restated 2017 Employee Stock Purchase Plan, as Amended.8-K10.26/18/2026
ExhibitNumberDescriptionIncorporatedby ReferenceFrom FormIncorporatedby ReferenceFrom ExhibitNumberDate Filed
31.1Certification Pursuant to Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer.Filed herewith
31.2Certification Pursuant to Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer.Filed herewith
32.1~Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer.Filed herewith
32.2~Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer.Filed herewith
101.INSInline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL documentFiled herewith
101.SCHInline XBRL Taxonomy Extension Schema With Embedded Linkbase DocumentsFiled herewith
104Cover page formatted as Inline XBRL and contained in Exhibit 101Filed herewith
  • Portions of this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Standard BioTools agrees to furnish supplementally a copy of any omitted schedule or exhibit to the U.S. Securities and Exchange Commission upon request; provided that Standard BioTools may request confidential treatment pursuant to Rule 24b-2 under the Exchange Act for any exhibits or schedules so furnished.
  • Management compensation plan or arrangement.

~ In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 33-8238 and 34-47986, Final Rule: Management’s Report on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates them by reference.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.